Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jan 15, 2025; 16(1): 98322
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.98322
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.98322
Association of the glycemic background patterns and the diabetes management efficacy in poorly controlled type 2 diabetes
Ayşe N Erbakan, Müzeyyen Arslan Bahadır, Fatoş N Kaya, Büşra Güleç, Miraç Vural Keskinler, Özge Faydalıel, Banu Mesçi, Aytekin Oğuz, Department of Internal Medicine, Prof Dr Suleyman Yalcin City Hospital, Istanbul Medeniyet University, Istanbul 34722, Türkiye
Ümmügülsüm Aktemur Çelik, Department of Family Medicine, Istanbul Medeniyet University, Istanbul 34722, Türkiye
Author contributions: Erbakan AN and Oğuz A designed the study; Erbakan AN, Arslan Bahadır M, Kaya FN, Güleç B, Vural Keskinler M, Faydalıel Ö, Aktemur Çelik Ü and Mesçi B conducted the study; Erbakan AN, Arslan Bahadır M, Vural Keskinler M, and Mesçi B provided clinical advice; and Erbakan AN and Kaya FN supervised the study; Erbakan AN and Oğuz A wrote the paper.
Institutional review board statement: The protocol was approved by the Ethics Committee of the Istanbul Medeniyet University Goztepe Research and Training Hospital, (approval number 2021/0413).
Clinical trial registration statement: This study is registered at ClinTrials.gov. The registration identification number is NCT06385899.
Informed consent statement: All eligible patients were invited to participate in the study, and those who agreed were given a written informed consent.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at erbakan553@hotmail.com.
CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ayşe N Erbakan, MD, PhD, Researcher, Department of Internal Medicine, Prof Dr Suleyman Yalcin City Hospital, Istanbul Medeniyet University, Eğitim mah, Kadıköy, Istanbul 34722, Türkiye. 17330803003@ismu.edu.tr
Received: June 26, 2024
Revised: August 26, 2024
Accepted: October 30, 2024
Published online: January 15, 2025
Processing time: 156 Days and 14.1 Hours
Revised: August 26, 2024
Accepted: October 30, 2024
Published online: January 15, 2025
Processing time: 156 Days and 14.1 Hours
Core Tip
Core Tip: Twelve months of enhanced monitoring and facilitated access to hospital visits in patients with poorly controlled type 2 diabetes resulted in substantial improvements in glycemic control. However, the glycemic background of patients had a significant impact on the success of glycemic control. The group with newly diagnosed diabetes showed the most favorable results (mean glycated hemoglobin at 12 months, 6.3%), whereas the group with persistently poorly controlled diabetes exhibited the worst results (mean glycated hemoglobin at 12 months, 9.7%), suggesting that new approaches are needed to improve treatment efficacy.